pharmaceutical composition, sealed container, metered dose inhaler, and methods for treating a patient suffering or likely to suffer from a respiratory disorder, for improving the stability of a pharmaceutical composition and for reducing the global warming potential of a pharmaceutical composition.
It is a pharmaceutical composition. the composition comprises: (i) a drug component comprising at least one beclomethasone compound selected from beclomethasone and the pharmaceutically acceptable derivatives thereof and at least one long-acting beta-2 agonist； (ii) a propellant component comprising 1,1-difluoroethane (hfa-152a)； and (iii) glycerol.trata-se de uma composição farmacêutica. a composição compreende: (i) um componente de fármaco que compreende pelo menos um composto de beclometasona selecionado entre a beclometasona e os derivados farmaceuticamente aceitáveis da mesma e pelo menos um agonista beta-2 de longa duração； (ii) um componente propulsor que compreende 1,1-difluoroetano (hfa-152a)； e (iii) glicerol.
